Doublet BRAF/MEK inhibition versus single-agent BRAF inhibition in the management of BRAF-mutant advanced melanoma, biological rationale and meta-analysis of published data
Crossref DOI link: https://doi.org/10.1007/s12094-015-1438-0
Published Online: 2015-10-30
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abdel-Rahman, O.
ElHalawani, H.
Ahmed, H.
Text and Data Mining valid from 2015-10-30